mRNA

News

AZ, Moderna say mRNA drug is promising in heart failure

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for he

News

FDA delays review of Moderna COVD jab in adolescents

The FDA has said it needs more time to review Moderna's application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to 17, as it looks at data on heart inflammation

Events

Partner Content

RNA Therapeutics 2022

Bolstering the latest advances and opportunities in RNA

News

Sanofi abandons mRNA COVID jab, despite positive trial

Sanofi has said that it won't develop its mRNA-based vaccine for COVID-19 any further, even though it seemed to work in an early-stage trial, and will focus instead on another candidate par

News

Sanofi swoops on partner Translate, buying the mRNA firm for...

Sanofi has been forging ever-closer ties with its mRNA partner Translate Bio since the two started working together in 2018, and has now gone all in, offering $3.2 billion to buy the compan

News

BioNTech's mRNA vaccine drive now includes malaria, TB shots

Flushed with the success of its COVID-19 vaccine, BioNTech has pressed the accelerator on the development of shots for other infectious diseases, and now plans to take malaria and tuberculo

AZ, Moderna say mRNA drug is promising in heart failure

FDA delays review of Moderna COVD jab in adolescents

RNA Therapeutics 2022

Sanofi abandons mRNA COVID jab, despite positive trial

Sanofi swoops on partner Translate, buying the mRNA firm for...

BioNTech's mRNA vaccine drive now includes malaria, TB shots

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

mRNA

Editor's Picks